Evidence map›Paper›PMID 26746209›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis.

Heidi S Donovan, Teresa L Hagan, Grace B Campbell, Michelle M Boisen, Leah M Rosenblum, Robert P Edwards, Dana H Bovbjerg, Charles C Horn

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Microbiome-gut-brain axis in cancer treatment-related psychoneurological toxicities and symptoms: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Pooled it
  2. Joint nausea and fatigue profiles during chemotherapy identify patients with a higher symptom burden.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  7. Postdischarge Nausea and Vomiting and Co-occurring Symptoms in Women Following Breast Cancer Surgery.Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses · 2023
    Observational
  8. Article
  9. Article
  10. Article
  11. Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  12. Revisiting the physiology of nausea and vomiting-challenging the paradigm.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Review
  13. Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Heidi S DonovanSchool of Nursing, University of Pittsburgh, 415 Victoria Building, 3500 Victoria Street, Pittsburgh, PA, 15261, USA. donovanh@pitt.edu.
Teresa L HaganSchool of Nursing, University of Pittsburgh, 415 Victoria Building, 3500 Victoria Street, Pittsburgh, PA, 15261, USA.
Grace B CampbellSchool of Nursing, University of Pittsburgh, 415 Victoria Building, 3500 Victoria Street, Pittsburgh, PA, 15261, USA.
Michelle M BoisenUniversity of Pittsburgh Cancer Institute, 5115 Centre Avenue, Pittsburgh, PA, 15232, USA.
Leah M RosenblumSchool of Nursing, University of Pittsburgh, 415 Victoria Building, 3500 Victoria Street, Pittsburgh, PA, 15261, USA.
Robert P EdwardsUniversity of Pittsburgh Cancer Institute, 5115 Centre Avenue, Pittsburgh, PA, 15232, USA.
Dana H BovbjergUniversity of Pittsburgh Cancer Institute, 5115 Centre Avenue, Pittsburgh, PA, 15232, USA.
Charles C HornUniversity of Pittsburgh Cancer Institute, 5115 Centre Avenue, Pittsburgh, PA, 15232, USA.
University of Pittsburgh · USUPMC Hillman Cancer Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-DirectedR01NR010735 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONOVAN, HEIDI S · 2008 to 2012
$2.8M
PATIENT-CENTERED INFORMATIONAL INTERVENTIONST32NR007102 · NINR · UNIVERSITY OF WISCONSIN-MADISON · PI WARD, SANDRA E · 1999 to 2009
$2.1M
A COMMON-SENSE ANALYSIS OF MULTI-SYMPTOM MANAGEMENTF31NR007556 · NINR · UNIVERSITY OF WISCONSIN MADISON · PI DONOVAN, HEIDI S · 2000 to 2002
$76k
NCI NIH HHS P30 CA047904NINR NIH HHS F31 NR007556NINR NIH HHS R01 NR010735NINR NIH HHS T32 NR007102
6 · The paper itself

Abstract

purposeNausea is a common and potentially serious effect of cytotoxic chemotherapy for recurrent ovarian cancer and may function as a sentinel symptom reflecting adverse effects on the gut-brain axis (GBA) more generally, but research is scant. As a first exploratory test of this GBA hypothesis, we compared women reporting nausea to women not reporting nausea with regard to the severity of other commonly reported symptoms in this patient population.

methodsA secondary analysis of data systematically collected from women in active chemotherapy treatment for recurrent ovarian cancer (n = 158) was conducted. The Symptom Representation Questionnaire (SRQ) provided severity ratings for 22 common symptoms related to cancer and chemotherapy. Independent sample t tests and regression analyses were used to compare women with and without nausea with regard to their experience of other symptoms.

resultsNausea was reported by 89 (56.2 %) women. Symptoms that were significantly associated with nausea in bivariate and regression analyses included abdominal bloating, bowel disturbances, dizziness, depression, drowsiness, fatigue, headache, lack of appetite, memory problems, mood swings, shortness of breath, pain, sleep disturbance, urinary problems, vomiting, and weight loss. Symptoms that were not associated with nausea included hair loss, numbness and tingling, sexuality concerns, and weight gain.

conclusionsNausea experienced during chemotherapy for recurrent ovarian cancer may be an indicator of broader effects on the gut-brain axis. A better understanding of the mechanisms underlying these effects could lead to the development of novel supportive therapies to increase the tolerability and effectiveness of cancer treatment.

Indexed as

Antineoplastic AgentsBrainEnteric Nervous SystemFemaleGastrointestinal TractHumansMiddle AgedNauseaNeoplasm Recurrence, LocalOvarian NeoplasmsSurveys and QuestionnairesVomitingAntineoplastic AgentsChemotherapy-induced nausea and vomitingGut-brain axisOvarian cancerSymptom assessment

Identifiers

PMID26746209
PMCPMC4846512
OpenAlexW2224787246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.